Efficacy of Viable Cartilage Allograft in talar osteochondral lesions

Not Applicable

• Conditions: Osteochondral Lesion in the Talus; Injuries and Accidents - Other injuries and accidents; Musculoskeletal - Other muscular and skeletal disorders

• Registration Number: ACTRN12624000412538
• Lead Sponsor: Sydney Orthopaedic Foot and Ankle Research Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2024-04-04
• Last Update Posted: 8 April 2024

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Patients between the ages of 18 to 65 (inclusive) undergoing surgery to treat talar osteochondral lesions will be included.

Exclusion Criteria

Exclusion criteria will be bilateral surgery, revision procedures, not willing to participate in the trial, cognitive impairment that may impair the patient’s ability to follow post-operative instructions or unable to provide informed consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Foot and Ankle Outcome Score[FAOS score Baseline, 6 weeks, 3, 6 and 12 months post surgery]

Secondary Outcome Measures

Name	Time	Method
General Health[VR-12 Baseline, 6 weeks, 3, 6 and 12 months post surgery];Radiology for lesion resolution[MRI 3, 6 and 12 months post surgery];Radiology for lesion resolution[Xrays 6 weeks, 3, 6 and 12 months post surgery];Adverse Events[E.g. infection, fractures, deep vein thrombosis etc.<br>Patient self-reported or investigator reported 2, 6 weeks; 3, 6 and 12 months post surgery]